242 related articles for article (PubMed ID: 36940072)
1. Anticancer Activity of Diosgenin and Its Molecular Mechanism.
Ren QL; Wang Q; Zhang XQ; Wang M; Hu H; Tang JJ; Yang XT; Ran YH; Liu HH; Song ZX; Liu JG; Li XL
Chin J Integr Med; 2023 Aug; 29(8):738-749. PubMed ID: 36940072
[TBL] [Abstract][Full Text] [Related]
2. Diosgenin: An Updated Pharmacological Review and Therapeutic Perspectives.
Semwal P; Painuli S; Abu-Izneid T; Rauf A; Sharma A; Daştan SD; Kumar M; Alshehri MM; Taheri Y; Das R; Mitra S; Emran TB; Sharifi-Rad J; Calina D; Cho WC
Oxid Med Cell Longev; 2022; 2022():1035441. PubMed ID: 35677108
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic Potential of Diosgenin and Its Major Derivatives against Neurological Diseases: Recent Advances.
Cai B; Zhang Y; Wang Z; Xu D; Jia Y; Guan Y; Liao A; Liu G; Chun C; Li J
Oxid Med Cell Longev; 2020; 2020():3153082. PubMed ID: 32215172
[TBL] [Abstract][Full Text] [Related]
4. [Research on anti-tumor natural product diosgenin].
Zhang SQ; Song YX; Zhang WX; Chen MJ; Man SL
Zhongguo Zhong Yao Za Zhi; 2021 Sep; 46(17):4360-4366. PubMed ID: 34581038
[TBL] [Abstract][Full Text] [Related]
5. Diosgenin as a Novel Alternative Therapy for Inhibition of Growth, Invasion, and Angiogenesis Abilities of Different Glioblastoma Cell Lines.
Khathayer F; Ray SK
Neurochem Res; 2020 Oct; 45(10):2336-2351. PubMed ID: 32683533
[TBL] [Abstract][Full Text] [Related]
6. Anticancer Activity of Diosgenin and Its Semi-synthetic Derivatives: Role in Autophagy Mediated Cell Death and Induction of Apoptosis.
Bhardwaj N; Tripathi N; Goel B; Jain SK
Mini Rev Med Chem; 2021; 21(13):1646-1665. PubMed ID: 33402081
[TBL] [Abstract][Full Text] [Related]
7. Diosgenin, a steroidal saponin, inhibits migration and invasion of human prostate cancer PC-3 cells by reducing matrix metalloproteinases expression.
Chen PS; Shih YW; Huang HC; Cheng HW
PLoS One; 2011; 6(5):e20164. PubMed ID: 21629786
[TBL] [Abstract][Full Text] [Related]
8. Pro-Apoptotic and Anti-Cancer Properties of Diosgenin: A Comprehensive and Critical Review.
Sethi G; Shanmugam MK; Warrier S; Merarchi M; Arfuso F; Kumar AP; Bishayee A
Nutrients; 2018 May; 10(5):. PubMed ID: 29783752
[TBL] [Abstract][Full Text] [Related]
9. Diosgenin, a steroid saponin of Trigonella foenum graecum (Fenugreek), inhibits azoxymethane-induced aberrant crypt foci formation in F344 rats and induces apoptosis in HT-29 human colon cancer cells.
Raju J; Patlolla JM; Swamy MV; Rao CV
Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1392-8. PubMed ID: 15298963
[TBL] [Abstract][Full Text] [Related]
10. Potential chemotherapeutic effects of diosgenin, zoledronic acid and epigallocatechin-3-gallate on PE/CA-PJ15 oral squamous cancer cell line.
Pons-Fuster López E; Wang QT; Wei W; López Jornet P
Arch Oral Biol; 2017 Oct; 82():141-146. PubMed ID: 28641180
[TBL] [Abstract][Full Text] [Related]
11. Diosgenin inhibits the proliferation, migration and invasion of the optic nerve sheath meningioma cells via induction of mitochondrial-mediated apoptosis, autophagy and G0/G1 cell cycle arrest.
Zhu X; Chen Z; Li X
J BUON; 2020; 25(1):508-513. PubMed ID: 32277676
[TBL] [Abstract][Full Text] [Related]
12. Antineoplastic and apoptotic potential of traditional medicines thymoquinone and diosgenin in squamous cell carcinoma.
Das S; Dey KK; Dey G; Pal I; Majumder A; MaitiChoudhury S; kundu SC; Mandal M
PLoS One; 2012; 7(10):e46641. PubMed ID: 23077516
[TBL] [Abstract][Full Text] [Related]
13. Diosgenin a steroidal compound: An emerging way to cancer management.
Arya P; Kumar P
J Food Biochem; 2021 Dec; 45(12):e14005. PubMed ID: 34799857
[TBL] [Abstract][Full Text] [Related]
14. Diosgenin and GSK126 Produce Synergistic Effects on Epithelial-Mesenchymal Transition in Gastric Cancer Cells by Mediating EZH2 via the Rho/ROCK Signaling Pathway.
Liu S; Rong G; Li X; Geng L; Zeng Z; Jiang D; Yang J; Wei Y
Onco Targets Ther; 2020; 13():5057-5067. PubMed ID: 32606728
[TBL] [Abstract][Full Text] [Related]
15. Diosgenin promotes antitumor immunity and PD-1 antibody efficacy against melanoma by regulating intestinal microbiota.
Dong M; Meng Z; Kuerban K; Qi F; Liu J; Wei Y; Wang Q; Jiang S; Feng M; Ye L
Cell Death Dis; 2018 Oct; 9(10):1039. PubMed ID: 30305604
[TBL] [Abstract][Full Text] [Related]
16. The Effects of Diosgenin on Hypolipidemia and Its Underlying Mechanism: A Review.
Sun F; Yang X; Ma C; Zhang S; Yu L; Lu H; Yin G; Liang P; Feng Y; Zhang F
Diabetes Metab Syndr Obes; 2021; 14():4015-4030. PubMed ID: 34552341
[TBL] [Abstract][Full Text] [Related]
17. Advances in the pharmacological activities and mechanisms of diosgenin.
Chen Y; Tang YM; Yu SL; Han YW; Kou JP; Liu BL; Yu BY
Chin J Nat Med; 2015 Aug; 13(8):578-87. PubMed ID: 26253490
[TBL] [Abstract][Full Text] [Related]
18. Diosgenin inhibits the expression of NEDD4 in prostate cancer cells.
Zhang J; Xie JJ; Zhou SJ; Chen J; Hu Q; Pu JX; Lu JL
Am J Transl Res; 2019; 11(6):3461-3471. PubMed ID: 31312358
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in chemical synthesis, biocatalysis, and biological evaluation of diosgenin derivatives - A review.
Fan R; He W; Fan Y; Xu W; Xu W; Yan G; Xu S
Steroids; 2022 Apr; 180():108991. PubMed ID: 35217033
[TBL] [Abstract][Full Text] [Related]
20. Diosgenin attenuates tumor growth and metastasis in transgenic prostate cancer mouse model by negatively regulating both NF-κB/STAT3 signaling cascades.
Sikka S; Shanmugam MK; Siveen KS; Ong TH; Yang MH; Lee JH; Rajendran P; Chinnathambi A; Alharbi SA; Alahmadi TA; Vali S; Kumar AP; Sethi G; Wang L; Hui KM; Ahn KS
Eur J Pharmacol; 2021 Sep; 906():174274. PubMed ID: 34146587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
